guo
tang
xudong
j
llg
wang
weidong
tj
ni
qing
q
n
zhang
jinp
j
wu
hongjin
zhou
wei
n
geng
zhi
l
ig
yangbo
n
lz
liang
zhiwei
liyun
ng
gao
fanzhu
njslt
peng
jin
n
abstract
object
evalu
effect
treatment
integr
chines
western
medicin
icwm
arteri
oxygen
satur
patient
sever
acut
respiratori
syndrom
sar
method
nonrandom
control
trial
conduct
sar
patient
treat
synchron
western
convent
treatment
wm
group
n
alon
icwm
icwm
group
n
chang
case
normal
level
abnorm
level
saoz
observ
dynam
result
day
therapeut
cours
percentag
patient
normal
icwm
group
higher
wm
group
p
tendenc
evid
patient
sever
type
p
howev
statist
signific
differ
shown
patient
icwm
treatment
start
earli
period
onset
day
p
shown
receiv
icwm
treatment
later
midlat
period
sar
appar
lower
blood
oxygen
satur
saoz
induc
acut
pulmonari
injuri
import
clinic
manifest
acut
sever
respiratori
syndrom
sar
order
verifi
efficaci
integr
chines
western
medicin
icwm
treat
sar
dynam
chang
arteri
saoz
icwm
treat
group
simpl
western
medicin
wm
treat
group
analyz
understand
possibl
exist
differ
subject
enrol
studi
sar
patient
whose
diagnosi
fit
clinic
diagnost
criteria
sever
acut
respiratori
syndrom
sar
issu
ministri
health
agre
trial
unconfirm
diagnosi
pregnanc
lactat
refus
particip
observ
exclud
eight
hospit
design
sar
treantment
variou
district
beij
chosen
clinic
observ
unit
base
condit
unit
select
observ
patient
hospit
may
june
ward
similar
condit
met
abovement
criteria
inclus
assign
wm
group
receiv
convent
treatment
wm
alon
icwm
group
treat
convent
wm
treatment
supplement
chines
medicin
patient
collect
patient
exclud
due
diagnosi
inconsist
sar
diagnost
criteria
due
incomplet
materi
accumul
observ
time
day
miss
followup
transffer
hospit
due
lack
record
foremost
day
hospit
therefor
case
remain
includ
analyz
age
sex
ill
type
stage
diseas
list
detail
tabl
shown
time
enrol
differ
two
group
signific
p
aspect
age
stage
diseas
insignific
aspect
sex
ill
type
p
wm
convent
treatment
refer
sar
treatment
regimen
z
recommend
ministri
health
given
patient
group
also
support
therapi
given
includ
respiratori
support
corticosteroid
cs
treatment
mode
paramet
respiratori
support
use
patient
common
type
oxygen
inhal
given
routin
nasal
tube
mask
minimum
flow
lmin
concentr
oxygen
around
patient
sever
type
noninvas
mechan
ventil
use
respir
facial
nasal
hilevel
posit
airway
pressur
bipap
oxygen
minimum
flow
lrain
inspiratori
posit
airway
pressur
ipap
begin
cm
scale
cm
expiratori
posit
airway
pressur
epap
cs
treatment
given
accord
condit
pulmonari
inflamm
use
mainli
methylprednisolon
daili
dosag
mg
sever
case
might
went
mg
even
maximum
mg
tcm
treatment
regimen
use
basi
syndrom
differenti
refer
technic
regimen
chines
medicin
treat
prevent
sar
draft
issu
state
administr
tradit
chines
medicin
patient
earli
stage
day
onset
syndrom
type
heattoxin
evil
invad
fei
n
treat
principl
clear
heat
ventil
fei
dispers
exterior
emancip
collater
use
modifi
yinqiao
powder
combin
max
shigan
decoct
l
l
syndrom
type
heatdamp
obstruct
principl
ventil
dampheat
drive
evil
pathogen
outward
use
modifi
sanren
decoct
fn
combin
shengjiang
powder
pv
damp
sever
heat
huopu
xial
decoct
b
n
could
chosen
use
syndrom
type
cold
exteriorheat
interior
complic
damp
principl
resolv
exterior
clear
intern
heat
dispers
fei
remov
damp
use
modifi
max
shigan
decoct
l
n
combin
shengjiang
powder
patient
middl
stage
onset
syndrom
type
epidem
toxin
invad
fei
heat
exuber
exterior
interior
principl
clear
heat
reliev
toxic
purg
fei
lower
revers
flow
qi
use
qingfei
jiedu
decoct
n
n
f
syndrom
type
dampheat
bound
toxin
principl
remov
damp
depriv
foul
clear
heat
reliev
toxic
use
modifi
ganlu
xiaodu
pill
n
syndrom
type
accumul
dampheat
obstruct
shaoyang
meridian
principl
clear
purg
shaoyang
meridian
elimin
damp
heat
chosen
modifi
haoqin
qingdan
decoct
nn
syndrom
type
exuber
heattoxin
principl
clear
heat
cool
blood
purg
fire
reliev
toxic
chosen
modifi
qingwen
baidu
decoct
nijn
patient
late
stage
usual
around
day
onset
syndrom
type
phlegmdamp
toxin
stagnanc
obstruct
fei
collater
principl
replenish
qi
reliev
toxic
remov
phlegm
damp
cool
blood
dredg
collater
chosen
huoxu
xiefei
decoct
n
n
syndrom
type
dampheat
obstruct
fei
qiyin
damag
principl
clear
heat
remov
damp
tonifi
qi
nourish
yin
chosen
yifei
huazhuo
decoct
n
syndrom
type
evil
promin
vital
qi
asthenia
interior
blockag
asthma
collaps
principl
replenish
qi
consolid
collaps
dissolv
blockag
open
orific
chosen
modifi
shenfu
decoct
patient
rehabilit
stage
day
onset
syndrom
type
qiyin
damag
residu
evil
principl
replenish
qi
nourish
yin
remov
damp
free
collater
chosen
modifi
li
qingshu
yiqi
decoct
j
il
n
syndrom
type
feipi
defici
principl
replenish
qi
activ
pi
appli
modifi
shenl
baishu
powder
combin
gegen
qinlian
decoct
dosag
form
chines
herbal
medicin
use
mainli
decoct
though
sometim
inject
chines
patent
drug
could
select
analysi
dynam
chang
treatment
sar
patient
detect
take
ml
arteri
blood
anticoagul
small
amount
heparin
isol
air
immedi
sent
bloodga
analyz
examin
regard
normal
abnorm
data
adjust
regard
factor
age
type
stage
diseas
treatment
cours
differ
differ
stage
earli
middl
late
compar
differ
treatment
cours
diseas
type
analyz
level
level
model
set
observ
perform
period
hospit
patient
till
clinic
improv
discharg
death
drop
followup
due
transfer
hospit
case
report
form
chang
condit
diseas
treatment
measur
fill
time
doctor
charg
variou
hospit
observ
unit
fax
data
manag
center
everi
day
complet
correct
data
confirm
form
check
error
adjust
sourc
data
verif
correct
entri
data
made
two
person
separ
databas
creat
microsoft
access
statist
analysi
softwar
spss
data
check
logic
scope
correct
sortedout
data
frequenc
analyz
x
test
rank
sum
test
asbnorm
distribut
measur
data
analyz
rank
sum
test
differ
group
compar
gener
linear
mix
model
establish
sa
softwar
packag
research
protocol
approv
ethic
committe
guanganmen
hospit
china
academi
tcm
enrol
patient
inform
test
consent
oral
accept
respect
icwm
simpl
wm
treatment
regimen
discharg
criteria
sar
issu
ministri
health
taken
evalu
clinic
improv
use
basi
discharg
see
tabl
differ
two
group
number
patient
shown
fig
insignific
differ
level
express
percentag
patient
abnorm
level
abbrevi
pp
two
group
whole
treatment
cours
p
comparison
model
creat
stratif
indic
baselin
stage
day
insignific
differ
comparison
pp
two
group
treat
pp
icwm
group
lower
wm
group
p
tendenc
evid
patient
se
insignific
differ
term
lower
risk
abnorm
level
common
type
patient
two
group
l
p
far
patient
sever
type
concern
comparison
two
group
show
better
therapeut
effect
icwm
group
wm
group
p
pp
patient
two
group
treatment
start
earli
stage
day
onset
shown
fig
indic
condit
obvious
better
icwm
group
wm
group
within
day
therapeut
courset
show
signific
differ
p
howev
differ
insignific
cours
day
day
patient
treatment
start
middl
day
onset
late
onset
stage
insignific
differ
shown
comparison
pp
two
group
either
total
cours
differ
partial
cours
treatment
see
fig
present
studi
prove
manifest
sar
acut
diffus
pulmonari
damag
adult
respiratori
distress
syndrom
ard
patholog
mechan
mainli
reproduct
viruscaus
respiratori
mucou
membran
epitheli
alveolar
cell
necrosi
immun
injuri
simultan
secondari
immun
injuri
consid
possibl
key
link
pulmonari
damag
sar
product
produc
mucou
membran
epitheli
cell
alveolar
cell
necrosi
would
stimul
tissu
produc
inflammatori
medium
induc
increas
alveolar
septum
capillari
permeabl
caus
inflammatori
exud
result
widen
alveolar
septa
enlarg
airblood
barrier
interstiti
space
final
lead
ventil
disturb
diseas
progress
concentr
increas
exud
form
homogen
transpar
membran
stick
alveolar
wall
thu
aggrav
air
exchang
disturb
time
larg
amount
exud
fluid
fill
bronchial
lumen
caus
obstruct
aggrav
ventil
disturb
induc
seriou
hypoxia
organ
present
standard
therapeut
agent
cure
sar
includ
antivir
agent
glucocorticoid
antibiot
immunomodul
etc
although
major
specialist
clinic
medicin
base
therapeut
experi
treat
similar
diseas
held
agent
benefici
treat
sar
still
lack
convinc
evid
studi
indic
icwm
treatment
chines
herbal
medicin
ad
help
improv
patientssymptom
recov
immun
function
etc
report
effect
seen
studi
problem
regard
obtain
data
owe
limit
condit
studi
incongru
time
point
measur
unbalanc
factor
brought
nonrandom
time
patient
check
differ
time
point
must
exist
problem
imbal
repeat
data
differ
time
span
gener
linear
mix
model
sa
softwar
packag
use
present
studi
establish
longitudin
data
logist
model
influenc
factor
regul
well
resolv
problem
therefor
conclus
need
studi
confirm
found
studi
treatment
combin
intervent
therapi
chines
herbal
medicin
ie
icwm
use
day
patient
recov
abil
maintain
level
treat
wm
alon
obviou
patient
sever
type
analysi
indic
patient
treat
earli
intervent
day
chines
medicin
differ
efficaci
icwm
wm
group
signific
intervent
treatment
appli
middl
late
stage
day
onset
differ
insignific
abovement
result
indic
icwm
treatment
could
evid
improv
patient
efficaci
earli
intervent
could
yield
better
result
defici
exist
present
studi
exampl
studi
origin
design
random
control
trial
owe
limit
condit
observ
case
underw
fulli
random
distribut
time
record
made
part
case
caus
incomplet
data
made
studi
liabl
potenti
deviat
select
